EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine
By asianet
EpiVax, Inc. (“EpiVax”) is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine epitope selection portion of the collaboration using their comprehensive in silico vaccine design toolkit “iVAX” ( https://c212.net/c/link/?t=0&l=en&o=3692683-1&h=2887996362&u=https%3A%2F%2Fepivax.com%2Fimmunogenicity-assessment%2Fivax-web-based-vaccine-design&a=their+comprehensive+in+silico+vaccine+design+toolkit+%22iVAX%22 ). … Continued